Barriers to the diagnosis and treatment of venous thromboembolism in advanced cancer patients: a qualitative study.

Item

http://www.wikidata.org/entity/Q40070964

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Barriers to the diagnosis and ...... patients: a qualitative study.

@en

Barriers to the diagnosis and ...... patients: a qualitative study.

@en-gb

type

Item

label

Barriers to the diagnosis and ...... patients: a qualitative study.

@en

Barriers to the diagnosis and ...... patients: a qualitative study.

@en-gb

prefLabel

Barriers to the diagnosis and ...... patients: a qualitative study.

@en

Barriers to the diagnosis and ...... patients: a qualitative study.

@en-gb

P1476

Barriers to the diagnosis and ...... patients: a qualitative study.

@en

P2093

Anthony Maraveyas

http://www.w3.org/2001/XMLSchema#string

Hayley Prout

http://www.w3.org/2001/XMLSchema#string

Ian Watt

http://www.w3.org/2001/XMLSchema#string

Laura Sheard

http://www.w3.org/2001/XMLSchema#string

P2860

Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer

Venous thrombosis in cancer patients: insights from the FRONTLINE survey

Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups

Suboptimal doses of low molecular weight heparin and acute venous thromboembolism. Data from the RIETE registry.

Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data.

The use of long-term low-molecular weight heparin for the treatment of venous thromboembolism in palliative care patients with advanced cancer: a case series of sixty two patients.

Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines

Management of venous thromboembolism (VTE) in cancer patients: ESMO Clinical Practice Guidelines.

Diagnosis and management of people with venous thromboembolism and advanced cancer: how do doctors decide? A qualitative study.

P304

339-348

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0269216312461678

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Simon Noble

Dawn Dowding

Miriam J Johnson

P577

2012-10-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232649004

http://www.w3.org/2001/XMLSchema#string

P698

23093572

http://www.w3.org/2001/XMLSchema#string

P921

venous thromboembolism